Loading clinical trials...

Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye | Clinical Trials | Clareo Health

Not Yet RecruitingNANCT05121493

Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye

This is a single center double-masked study with up to four visits. Subjects who have been diagnosed with dry-eye syndrome at Flaum Eye Institute will be enrolled. The purpose of the study is to deter...

Lead sponsor: University of Rochester•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

James Aquavella, MD

CONTACT

585-273-3937 james_aquavella@urmc.rochester.edu

Related studies

RECRUITINGNA

Clinical Applications of Advanced Ophthalmic Imaging

NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more

RECRUITING

Assessment of TFT by OCT in Healthy Subjects and Subjects With DES

NCT02585414 · Dry Eye Syndromes

RECRUITINGNA

Difference of Tear Ferning Between Women with and Without Menopausal.

NCT06848829 · Dry Eye Syndromes

RECRUITINGNA

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NCT06220474 · Dry Eye Syndromes, Meibomian Gland Dysfunction

RECRUITINGPhase 3

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

NCT06291194 · Dry Eye Syndromes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 26, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment15

Start dateOct 2025

Last updatedNov 26, 2024

Condition

Dry Eye Syndromes

Locations shown

Flaum Eye Institute at the University of Rochester

Rochester, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 26, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Contacts

Sponsors

Related studies

Clinical Applications of Advanced Ophthalmic Imaging

Assessment of TFT by OCT in Healthy Subjects and Subjects With DES

Difference of Tear Ferning Between Women with and Without Menopausal.

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Trial snapshot

Condition

Locations shown

For caregivers